Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary biliary cirrhosis: a Mount Sinai perspective.

Nancy Bach1, Joseph A Odin

  • 1Division of Liver Diseases, Department of Medicine, Box 1123, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.

The Mount Sinai Journal of Medicine, New York
|September 12, 2003
PubMed
Summary

Primary biliary cirrhosis (PBC) involves bile duct destruction, leading to cirrhosis. Research at Mount Sinai expands understanding and treatment of this chronic liver disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical characteristics and HLA associations of azithromycin-induced liver injury.

Alimentary pharmacology & therapeutics·2024
Same author

Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience.

Obstetrics and gynecology·2024
Same author

First Report of Immunoglobulin G4-related Hepatic Inflammatory Pseudotumor in Transplanted Liver.

Transplantation·2023
Same author

Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.

Gastroenterology·2022
Same author

Value of liver biopsy in the diagnosis of drug-induced liver injury.

Journal of hepatology·2022
Same author

Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2021

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts.
  • Mount Sinai has a long history of significant contributions to understanding PBC's natural history and histopathology.
  • Currently, there is no cure for PBC, necessitating ongoing research and clinical management.

Purpose of the Study:

  • To detail recent clinical and basic science initiatives at the Center for the Study of Primary Biliary Cirrhosis at Mount Sinai.
  • To contextualize these new research efforts within the current understanding of PBC immunopathogenesis.
  • To highlight Mount Sinai's continued commitment to advancing PBC research and patient care.

Main Methods:

Related Experiment Videos

  • Review of ongoing clinical trials for PBC patients.
  • Description of basic science research projects focused on PBC.
  • Integration of historical contributions with current research directions.

    • Main Results:

    • Establishment of the Center for the Study of Primary Biliary Cirrhosis at Mount Sinai, supported by the Artzt Family Foundation Trust.
    • Expansion of both clinical and basic science research initiatives.
    • Focus on understanding the immunopathogenesis of PBC.

    Conclusions:

    • Mount Sinai is actively expanding research into primary biliary cirrhosis.
    • New initiatives aim to deepen the understanding of PBC's underlying mechanisms.
    • Continued efforts in clinical trials and liver transplantation are vital for managing PBC.